As of Apr 29
| -0.02 / -5.88%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 1.50, with a high estimate of 5.00 and a low estimate of 0.50. The median estimate represents a +368.75% increase from the last price of 0.32.
The current consensus among 3 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.